When you're a small biotech with no money and BP is doing everything they can to make you go under, you have few choices. That the Company has been able to raise funds the way it has is remarkable.

Comments about dilution from financing activities are disingenuous. How the Company has done it is 1,000,000% better than the death speak financing previous management was doing.